Core Viewpoint - Oriental Rise (ORIS) Holdings has entered into a non-binding letter of intent to acquire the PoDu white tea beverage brand, aligning with its long-term strategic objectives to enhance its white tea category and diversify product offerings [1] Group 1: Proposed Transaction Details - The acquisition involves PoDu, a ready-to-drink botanical tea beverage brand from Zherong County, Fujian Province, focusing on high-altitude white tea [1] - The transaction is subject to comprehensive due diligence, satisfactory results, and the execution of definitive agreements [1] - The completion of the transaction is contingent upon customary closing conditions [1] Group 2: Strategic Alignment and Benefits - The proposed acquisition is expected to complement Oriental Rise's existing tea garden resources in Zherong County, furthering its strategy of expanding across the tea value chain [1] - The company aims to enhance its product innovation, branding, distribution, and consumer product development through this acquisition [1] - Expected benefits include a diversified product mix, increased exposure to higher-margin consumer products, and improved ability to capture health-oriented demand trends [1] Group 3: Market Position and Growth Potential - Zherong County is recognized for its high-altitude tea-growing environment, which contributes to the production of premium tea leaves [1] - The combination of Oriental Rise's resources and PoDu's brand positioning is anticipated to strengthen brand presence and enhance operating leverage for future growth initiatives [1]

Proposed Transaction Expected to Expand Ready-to-Drink Product Portfolio, Enhance White Tea Value Chain, and Broaden Health-Oriented Consumption Scenarios NINGDE, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NASDAQ: ORIS), an integrated tea supplier in mainland China, today announced that it has entered into a non-binding letter of intent (“LOI”) to acquire the PoDu (“破独”) white tea beverage brand and certain related assets (the “Proposed Transa ...

Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) fell sharply during Friday's session after the company announced plans to raise fresh capital.Intelligent Bio said it will raise $10 million through a private placement, which weighed on shares following the announcement.Intelligent Bio Solutions shares dipped 19.7% to $7.65 on Friday.Here are some other stocks moving in today’s mid-day session.GainersLavoro Limited (NASDAQ:LVRO) jumped 181% to $1.2900.Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) rose 5 ...

Core Viewpoint - Premarket trading is showing notable activity with significant price movements indicating potential investment opportunities before the market opens [1] Group 1: Premarket Gainers - SMX (Security Matters) Public Limited Company (SMX) is up 39% at $22.80 [3] - Rubico Inc. (RUBI) has increased by 21% to $1.30 [3] - Aimei Health Technology Co., Ltd (AFJK) is up 19% at $76.80 [3] - Sable Offshore Corp. (SOC) has risen 19% to $10.81 [3] - Diginex Limited (DGNX) is up 18% at $4.95 [3] - Sidus Space, Inc. (SIDU) has increased by 18% to $3.71 [3] - SELLAS Life Sciences Group, Inc. (SLS) is up 16% at $4.40 [3] - Alchemy Investments Acquisition Corp 1 (ALCY) has risen 14% to $16.24 [3] - Greenidge Generation Holdings Inc. (GREE) is up 11% at $1.65 [3] - Enigmatig Limited (EGG) has increased by 5% to $5.52 [3] Group 2: Premarket Losers - Intelligent Bio Solutions Inc. (INBS) is down 11% at $8.48 [4] - ZW Data Action Technologies Inc. (CNET) has decreased by 11% to $1.20 [4] - Nuvve Holding Corp. (NVVE) is down 9% at $2.31 [4] - ESH Acquisition Corp. (ESHA) has fallen 8% to $17.59 [4] - LZ Technology Holdings Limited (LZMH) is down 6% at $1.55 [4] - Oriental Rise Holdings Limited (ORIS) has decreased by 4% to $1.43 [4] - Cango Inc. (CANG) is down 3% at $1.45 [4] - Massimo Group (MAMO) has fallen 2% to $3.90 [4] - Anghami Inc. (ANGH) is down 2% at $3.68 [4] - AIM ImmunoTech Inc. (AIM) has decreased by 2% to $1.10 [4]

智通财经APP获悉，周三，闽东红(ORIS.US)大涨逾25%，报1.53美元。消息面上，12月30日，闽东红宣 布签署无约束力的意向书收购Hubei Daguan Tea Industry Group控股权，旨在加强上游供应控制及优化产 品组合。资料显示，闽东红集团在中国福建省种植、加工和精炼白茶与红茶，并将茶叶销售给中国的分 销商和终端消费者。初级加工白茶是闽东红的核心产品。 ...

Core Viewpoint - U.S. stock futures are trading lower, with several companies making headlines due to significant stock movements following recent announcements and earnings reports [1] Group 1: Company Announcements - Oriental Rise Holdings Ltd. announced a nonbinding letter of intent to acquire a controlling stake in Hubei Daguan Tea Industry Group, leading to a 47.5% increase in its share price to $1.80 in after-hours trading [1] - Vanda Pharmaceuticals Inc. received FDA approval for NEREUS (tradipitant), resulting in a 20.2% surge in its share price to $8.45 in after-hours trading [1] - One Stop Systems Inc. agreed to sell all assets of Bressner Technology GmbH for $22.4 million, while also lowering its FY2025 sales guidance due to the discontinuation of Bressner, leading to a 1.7% increase in its share price to $7.27 in after-hours trading [1] Group 2: Earnings Reports - Ellomay Capital Ltd. reported third-quarter earnings of 93 cents per share, up from 52 cents per share in the previous year, with sales increasing to $14.944 million from $13.555 million, resulting in a 16.6% rise in its share price to $26.20 [1] - FuelCell Energy Inc. filed for a common stock offering of up to $200 million, causing a 5% decline in its share price to $7.54 in after-hours trading [1]

Core Viewpoint - The proposed acquisition of Hubei Daguan Tea Industry Group by Oriental Rise Holdings is expected to enhance upstream supply control, improve product mix, and advance the company's vertical integration strategy [1][2]. Company Overview - Oriental Rise Holdings Limited is an integrated tea supplier in mainland China, focusing on the cultivation, processing, and sale of tea products, including primarily-processed and refined white and black teas [8]. - The company operates tea gardens in Zherong County, Ningde City, Fujian Province, and serves both wholesale distributors and end-user retail customers [8]. Proposed Transaction Details - The company has entered into a non-binding letter of intent to acquire a controlling equity interest in Daguan Tea, a leading tea producer and processor based in Hubei Province [1][2]. - The transaction aims to strengthen control over core tea raw material resources, optimize cost structure, and enhance the development of higher value-added tea products [2]. Strategic Benefits - If completed, the acquisition is expected to generate strategic benefits by combining Oriental Rise's public company platform, capital market access, branding capabilities, and nationwide distribution network with Daguan Tea's upstream resources and production strengths [5]. - Anticipated benefits include improved supply stability and quality control, a more favorable product mix with increased exposure to higher-margin offerings, enhanced supply-chain coordination, and improved operating leverage for future growth initiatives [5]. Daguan Tea Overview - Daguan Tea is a vertically integrated tea enterprise with operations in tea cultivation, processing, product development, and brand management [3]. - The company has substantial self-owned tea plantation resources and modern production facilities capable of producing a wide range of tea products, including premium and export-grade teas [3][4]. Vertical Integration Strategy - The proposed acquisition reflects Oriental Rise's ongoing execution of its vertical integration strategy, focusing on expanding across the tea value chain from cultivation to export [6]. - Management emphasizes that securing upstream resources and production capacity is crucial for enhancing long-term competitiveness and earnings quality in the tea industry [7].

Group 1 - The core point of the article highlights the significant declines in the stock prices of several Chinese concept stocks, with notable drops exceeding 60% for some companies [1] Group 2 - JZXN (Jiuzhi New Energy) experienced a drop of 60.27%, closing at 0.425 with a trading volume of 3.9579 million [1] - MTEN (Ming Teng International) fell by 38%, closing at 6.200 with a trading volume of 2.2114 million [1] - YAAS (Youxin Technology) saw a decline of 32.89%, closing at 0.0451 with a trading volume of 4.1611 million [1] - EPOW (Huiyang New Energy) decreased by 26.91%, closing at 0.899 with a trading volume of 59.1834 million [1] - ORIS (Mindong Hong) dropped by 24.39%, closing at 0.2030 with a trading volume of 4.6224 million [1]

Group 1 - The top five gaining Chinese concept stocks at closing were: Mindong Hong up 43.85%, Skyline Construction Group up 40.76%, Yingxi Group up 30.51%, Huicheng Technology up 27.72%, and Junfu Financing up 25.73% [1] - Mindong Hong's latest price is 0.2280 with a gain of 43.85%, translating to an increase of 0.0695 and a trading volume of 63.41 million [1] - Skyline Construction Group's latest price is 3.350 with a gain of 40.76%, translating to an increase of 0.970 and a trading volume of 23.44 million [1] - Yingxi Group's latest price is 1.0800 with a gain of 30.51%, translating to an increase of 0.2525 and a trading volume of 9.59 million [1] - Huicheng Technology's latest price is 0.3700 with a gain of 27.72%, translating to an increase of 0.0803 and a trading volume of 14.59 million [1] - Junfu Financing's latest price is 4.300 with a gain of 25.73%, translating to an increase of 0.880 and a trading volume of 0.2392 million [1]

Group 1 - The top five gainers among Chinese concept stocks include: Mindonghong with a rise of 35.33%, Pitanium up by 21.27%, Heitong Technology increasing by 17.07%, Zhengye Biology rising 14.7%, and Mint up 14.24% [1] - Mindonghong (ORIS) closed at 0.1827 with a gain of 35.33%, translating to an increase of 0.0477 and a trading volume of 13.18 million [1] - Pitanium (PTNM) reached a price of 7.240, marking a 21.27% increase, which is an addition of 1.270 with a trading volume of 9.68 million [1] Group 2 - Heitong Technology (DKI) saw its stock price rise to 8.300, reflecting a 17.07% increase, equivalent to a gain of 1.210 and a trading volume of 4.25 million [1] - Zhengye Biology (ZYBT) closed at 10.690, with a 14.70% increase, amounting to a rise of 1.370 and a trading volume of 2.35 million [1] - Mint (MIMI) ended at 10.750, showing a 14.24% increase, which is an increase of 1.340 with a trading volume of 39.62 million [1]